Page breadcrumb nav

VAERS Report 2157308

Case Report Section

Détails du rapport Vaer

Âge: 60 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fe2707


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-07-12
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

burning eyes; oculomotor spasm; hairy skin itching; migraine; facial paraesthesia; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: it-minisal02-842718. a 60 year-old female patient (unknown if pregnant) received bnt162b2 (comirnaty), intramuscular, administered in arm left, administration date 12jul2021 (lot number: fe2707) at the age of 60 years as dose 1, single for covid-19 immunisation. relevant medical history included: "primary hyperparathyroidism" (unspecified if ongoing); "migraine" (unspecified if ongoing); "pulmonary nodule under investigation" (unspecified if ongoing), notes: under investigation. the patient's concomitant medications were not reported. the following information was reported: eye irritation (medically significant) with onset 12jul2021, outcome "not recovered", described as "burning eyes"; oculogyric crisis (medically significant) with onset 12jul2021, outcome "not recovered", described as "oculomotor spasm"; pruritus (medically significant) with onset 12jul2021, outcome "not recovered", described as "hairy skin itching"; migraine (medically significant) with onset 12jul2021, outcome "not recovered", described as "migraine"; paraesthesia (medically significant) with onset 12jul2021, outcome "not recovered", described as "facial paraesthesia". the patient underwent the following laboratory tests and procedures: quality of life decreased: (2021) 8/10; specialist consultation: (2021) unknown results. on 14feb2022: the seriousness of the suspected adverse reaction is updated from "serious or permanent invalidity" to "serious-other clinically relevant condition". reporter comment: primary hyperparathyroidism - migraine - pulmonary nodule under investigation - no follow-up attempts are possible. no further information is expected

Données de laboratoire
test date: 2021; test name: impact on quality of life; result unstructured data: test result:8/10; test date: 2021; test name: visit to oculist; result unstructured data: test result:unknown results
Liste des symptômes
paraesthesia pruritus migraine eye irritation quality of life decreased specialist consultation oculogyric crisis
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na